Navigation Links
Cha-Ching! Seniors Enrolled in Medicare Prescription Drug Plans Might Be in for Sticker Shock Next Year
Date:11/9/2007

nvision RxPlus Gold of New York, which increased total premium and drug costs 60 percent(4) - or $1,915 - from January 2007 to January 2008. This plan also had the highest increases in Florida and California, and Texas (along with Blue MedicareRx Standard), and was second only to Blue MedicareRx Standard in Illinois.

"It is so important to take the time and shop among plans, and use the Medicare website (http://www.Medicare.gov) to check your drug costs" Vaughan said, adding that CU found up to a $2,700 difference between the lowest and highest cost plan within a state for the five drugs sampled. "A plan that was a bargain this year may be the exact opposite next year. Beneficiaries have just a few weeks during open enrollment to avoid being stuck with a high cost plan in 2008."

While the majority of plans CU sampled increased overall costs, some plans kept costs low, or even reduced their costs from year to year.

In 2007, HealthSpring Prescription Drug Plan-Reg 22 had the fifth lowest overall drug costs of any plan in Texas for the five sampled drugs and premiums, and a 2008 cost increase of as little as 3 percent(5). This now makes it the least expensive plan in the state for the five drugs (in New York, Illinois and California the least expensive plans for these five drugs are also run by HealthSpring).

"It is essential that beneficiaries look carefully on the Medicare website and in the 'Medicare and You Handbook' for plans with prices that start low and stay low," Vaughan said.

Consumers Union also reminds beneficiaries that many could benefit by reviewing their drug options with their doctors and considering effective, lower-cost alternatives. Savings from moving to a generic or lower cost brand alternative might more than cover their Part D premiums. Information on the safest, most effective drugs is available, free, on the CU website,

SOURCE Consumers Union
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Oral Health a Matter of Life and Death for Seniors
2. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
3. Seniors Need a Safety Plan in Face of Disasters
4. High Co-Pays Cause Seniors to Go Without Meds
5. Study finds drug spending caps cause some seniors to quit taking key medicines
6. Medicare Spending Caps Cause Seniors to Stop Meds
7. New Report: Dangerous Drug Side Effects and Deaths Doubled Since 1998... Seniors Hit Hardest
8. Medicare Cuts to Physicians Will Harm Washington Seniors
9. Obesity Wont Affect Seniors Memory
10. Study finds drug spending caps cause some seniors to quit taking key medicines
11. New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...ndenses the blood and increases the risk of heart ...versity of Texas, it has been found that too many ... - in Britain. He believes that cold temperatures ...s thicker than normal. This raises the risk of clo...
...ecognised an amino-acid taste receptor.Dr Charles ... and the University of California, San Diego, repo... can identify five different tastes — bitter, salt...ur associated with monosodium glutamate (MSG).Rece...
...ke and have a history of alcohol problems have poo...most 400 patients// to find if there was a link be...ified them into four groups:current tobacco use on...th, or neither. The patients with both current to...
... that an air pollutant emitted by power plants and...ng can increase your chances of dying from lung ca...icles of air pollution. The study authors contend ...you to "fine particulate matter" that makes its wa...
Other Medicine News:Health News:Comprehension of taste receptor, 2
(Date:9/3/2008)...- Simcere,Pharmaceutical Gr...lier of,branded generic pharmaceuticals and manufa... Endu (also known as Endostar) in China,announced...dy., At the request of the SFDA, Simcere initiate...e safety and therapeutic efficacy of Endu, a modif...
(Date:9/3/2008)...EVA, Sept. 3 /- Artelis SA and,Selexi...monoclonal antibody,production with the achievemen...er. This record level was accomplished by applying...rformance stable Selexis CHO,production cell line ...t,Selexis SA using their proprietary Selexis Genet...
(Date:9/3/2008)...s, Updates Zingo Launch Progress and Adlea ... Conference Call Today at 11:30 am ET, SOUTH...all/ -- Anesiva,Inc. (Nasdaq: ANSV ) announced t...to focus on commercial and late-stage product deve...y pharmaceutical pain management,company. The comp...
(Date:9/2/2008)...wire-FirstCall/ -- Forest Laboratories, Inc.,(NYSE...ounced results from,two global Phase III studies o...anticholinergic for the treatment of patients with...both the ACCLAIM/COPD I&II,(AClidinium CLinical Tr...evere COPD Patients) studies, once-daily aclidiniu...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6Climate change has major impact on oceans 2245 1Climate change has major impact on oceans 2245 2Climate change has major impact on oceans 2245 3Climate change has major impact on oceans 2245 4Large changes needed to address global obesity epidemic 12109 1Large changes needed to address global obesity epidemic 12109 2Symposium on drug resistant diseases set for annual AAAS conference 12105 1MIT professor to discuss future of biofuels 2238 1MIT professor to discuss future of biofuels 2238 2
..., 2007 - CombinatoRx,Incorporated (NASDAQ: CRXX),...inded, placebo-controlled phase 2 clinical trials ...d rheumatoid,arthritis (RA) will be featured at th...l Congress of Rheumatology meeting, June,13-16, 20...Satellite Symposium, Room 111, Thursday, June 14, ...
...Waltham, Mass., June 7, 2007 – Dynogen Pharm...randomized, double-blind,placebo-controlled Phase...sease (GERD). The study was designed to demonstra...nocturnal GERD,(NGERD). The 0.5 mg dose of DDP73...n the primary endpoint of reduction in,the number ...
Other Medicine Technology:Novel Mechanism Insights and Additional Data on CombinatoRx Drug,Candidates to Be Presented at Upcoming EULAR Meeting 2Novel Mechanism Insights and Additional Data on CombinatoRx Drug,Candidates to Be Presented at Upcoming EULAR Meeting 3Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 2Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 3
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: